Jamol Uzokov

82 та иш

Republican Specialized Scientific-Practical Medical Center Therapy and Medical Rehabilitation, Tashkent, Uzbekistan

1. P427Influence of ranolazine on cardioversion rate in patients with new onset atrial fibrillation and ischemic disease of the heart

   Bakhromkhon Alyavi, Jamol Uzokov, Akbar Abdullaev +1

   МақолаCardiac electrophysiology and arrhythmiasEP Europace20201 иқтибос

   ABIABI:AkademIndex/openalex/2020.article.001167

2. Prognostic value of metabolic syndrome for the development of type 2 diabetes mellitus and cardiovascular disease

   A. L. Alyavi, Bakhromkhon Alyavi, Jamol Uzokov

   МақолаDiabetes, Cardiovascular Risks, and LipoproteinsAtherosclerosis20201 иқтибос

   ABIABI:AkademIndex/openalex/2020.article.001193

3. Impact of the COVID-19 pandemic on hospitalizations for acute coronary syndromes: a multinational study

   Diego Araiza‐Garaygordobil, C Montalto, Pablo Martínez-Amezcua +34

   МақолаCOVID-19 and healthcare impactsQJM20211 иқтибос

   ABIABI:AkademIndex/openalex/2021.article.000247

4. Clinical and angiographic characteristics and short-term outcomes of patients with non-ST elevation acute coronary syndrome with metabolic syndrome

   Jamol Uzokov, A. L. Alyavi, BA Alyavi +4

   МақолаCoronary Interventions and DiagnosticsEuropean Heart Journal Acute Cardiovascular Care20221 иқтибос

   ABIABI:AkademIndex/openalex/2022.article.001257

5. Targeting VCAM-1 with chimeric antigen receptor and regulatory T cell for abdominal aortic aneurysm treatment

   Qingwei Gang, Yu Lun, Xiaoxu Zhang +10

   МақолаCAR-T cell therapy researchCommunications Biology20251 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.000953

6. Influence of variability in risk factors on cardiovascular disease outcomes in type 2 diabetes mellitus

   Jamol Uzokov

   БошқаDiabetes, Cardiovascular Risks, and LipoproteinsEuropean Journal of Preventive Cardiology20231 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.586760

7. Efficacy and safety of combined antihypertensive therapy with ramipril and moxonidine in patients with metabolic syndrome

   Jamol Uzokov, Aniskhon Lutfullayevich Alyavi, Ilhom Yunuskhonovich Akhmedov +2

   МақолаBlood Pressure and Hypertension StudiesJournal of the American Society of Hypertension20160 иқтибос

   ABIABI:AkademIndex/openalex/2016.article.000281

8. Prevalence and characteristics of metabolic syndrome in patients with bronchial asthma

   Jamol Uzokov, Anis Alyavi, Baxrom Alyavi

   МақолаChronic Obstructive Pulmonary Disease (COPD) Research20170 иқтибос

   ABIABI:AkademIndex/openalex/2017.article.000475

9. TCTAP A-157 Short Term Outcomes After Percutaneous Interventions in Patients with Metabolic Syndrome

   Jamol Uzokov, Anis Alyavi, Bakhrom Alyavi

   МақолаHealth Systems, Economic Evaluations, Quality of LifeJournal of the American College of Cardiology20170 иқтибос

   ABIABI:AkademIndex/openalex/2017.article.000599

10. SP088INFLUENCE OF TELMISARTAN AND AMLODIPINE COMBINATION ON BLOOD PRESSURE, ECHOCARDIOGRAPHIC PARAMETERS AND MICROALBUMINURIA IN PATIENTS WITH METABOLIC SYNDROME

    Baxrom Alyavi, Jamol Uzokov, Sokhiba Kamilova

    МақолаHormonal Regulation and HypertensionNephrology Dialysis Transplantation20180 иқтибос

    ABIABI:AkademIndex/openalex/2018.article.000750

11. Low glycemic diet improves lipid profile in patients with coronary heart disease

    A. L. Alyavi, Bakhromkhon Alyavi, Jamol Uzokov

    МақолаLiver Disease Diagnosis and TreatmentAtherosclerosis20180 иқтибос

    ABIABI:AkademIndex/openalex/2018.article.000823

12. P3570Bilateral renal artery stenting is effective method for the treatment of uncontrolled hypertension and renal function

    Jamol Uzokov, A. L. Alyavi, Bakhromkhon Alyavi +2

    МақолаRenal and Vascular PathologiesEuropean Heart Journal20190 иқтибос

    ABIABI:AkademIndex/openalex/2019.article.000598

13. P269Prognostic role of coronary artery calcium score in patients with metabolic syndrome

    Jamol Uzokov, A. L. Alyavi, Bakhromkhon Alyavi +1

    МақолаCardiovascular Disease and AdiposityEuropean Heart Journal - Cardiovascular Imaging20190 иқтибос

    ABIABI:AkademIndex/openalex/2019.article.000638

14. Influence of combined lipid lowering therapy on lipid components and interleukins in dyslipidemic patients with coronary artery disease after PCI

    Jamol Uzokov, Bakhromkhon Alyavi, A. Abdullaev

    МақолаLipoproteins and Cardiovascular HealthAtherosclerosis20200 иқтибос

    ABIABI:AkademIndex/openalex/2020.article.000604

15. Efficacy of clopidogrel in patients with coronary artery disease after PCI considering with genetic polymorphisms

    Jamol Uzokov, B. A. Alyavi

    МақолаAntiplatelet Therapy and Cardiovascular DiseasesAtherosclerosis20200 иқтибос

    ABIABI:AkademIndex/openalex/2020.article.001189

16. P1001Efficacy of ranolazine for the prevention of atrial fibrillation in high-risk patients with chronic coronary syndrome and hypertension

    A. L. Alyavi, Bakhromkhon Alyavi, Jamol Uzokov +1

    МақолаSynthesis and Biological EvaluationEP Europace20200 иқтибос

    ABIABI:AkademIndex/openalex/2020.article.001222

17. Regional differences in presentation characteristics, use of treatments and outcome of patients with cardiogenic shock: Results from multicenter, international registry

    Michal Pazderník, Mario Gramegna, Allan Böhm +19

    МақолаMechanical Circulatory Support DevicesBiomedical Papers20210 иқтибос

    ABIABI:AkademIndex/openalex/2021.article.001052

18. Aspirin Resistance in Patients with Chronic Coronary Syndrome

    A. L. Alyavi, Sh.I.Khodjanova, Jamol Uzokov +1

    МақолаAntiplatelet Therapy and Cardiovascular DiseasesIndian Journal of Forensic Medicine & Toxicology20210 иқтибос

    ABIABI:AkademIndex/openalex/2021.article.002392

19. Antiplatelet therapy with clopidogrel taking into account CYP2C19 genetic polymorphisms in patients with coronary heart disease after coronary artery stenting

    Jamol Uzokov, B. A. Alyavi, A. Abdullaev +2

    МақолаAntiplatelet Therapy and Cardiovascular DiseasesAtherosclerosis20210 иқтибос

    ABIABI:AkademIndex/openalex/2021.article.008297

20. Statins and dementia: effect of statins beyond the treatment of dyslipidaemia

    Jamol Uzokov

    БошқаLipoproteins and Cardiovascular HealthEuropean Journal of Preventive Cardiology20210 иқтибос

    ABIABI:AkademIndex/openalex/2021.other.000002

21. Influence of sacubitril/valsartan on hibernating myocardium in patients with chronic heart failure with reduced ejection fraction

    M Mukhamedova, Dildora Saidjanovna Narzullaeva, Jamol Uzokov

    МақолаCardiovascular Function and Risk FactorsEuropean Journal of Cardiovascular Nursing20220 иқтибос

    ABIABI:AkademIndex/openalex/2022.article.001403

22. Does low glycemic index diet superior than routine diet to control blood inflammation state and lipid parameters in patients with coronary artery disease?

    A. L. Alyavi, Bakhromkhon Alyavi, Jamol Uzokov +4

    МақолаCardiovascular Disease and AdiposityEuropean Heart Journal20220 иқтибос

    ABIABI:AkademIndex/openalex/2022.article.001767

23. Influence of diet with low glycemic index on anthropometric parameters in patients with atherosclerotic coronary artery disease

    Djamshid Payziev, Bakhromkhon Alyavi, Jamol Uzokov +1

    МақолаNutritional Studies and DietEuropean Journal of Cardiovascular Nursing20220 иқтибос

    ABIABI:AkademIndex/openalex/2022.article.001907

24. Influence of sacubitril/valsartan on diastolic parameters in patients with chronic heart failure with reduced ejection fraction

    Jamol Uzokov, M G Mukhamedova, Dildora Saidjanovna Narzullaeva +3

    МақолаCardiovascular Function and Risk FactorsEuropean Journal of Cardiovascular Nursing20220 иқтибос

    ABIABI:AkademIndex/openalex/2022.article.002274

25. Short-term outcomes of catheter ablation in atrial fibrillation in patients with metabolic syndrome

    Jamol Uzokov, BA Alyavi, DD Payziev +2

    МақолаAtrial Fibrillation Management and OutcomesEP Europace20220 иқтибос

    ABIABI:AkademIndex/openalex/2022.article.005098